Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic
steatohepatitis (NASH), represents the fastest growing indication for liver transplantation in …

Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …

Hepatocellular carcinoma (HCC) is the most rapidly increasing cause of cancer death in the
United States. Although many risk factors for HCC are well defined, including hepatitis B …

Although renal transplantation ameliorates cardiovascular risk factors by restoring renal
function, it introduces new cardiovascular risks including impaired glucose tolerance or …

Hepatitis C virus (HCV) infection has a detrimental role on patient and graft survival after
renal transplantation (RT). Some studies have also implicated HCV in the development of …

Type 2 diabetes mellitus (T2DM) is an endocrine disorder encompassing multifactorial
mechanisms, and chronic hepatitis C virus infection (CHC) is a multifaceted disorder …

This review focuses on the relationship between hepatitis C virus (HCV) infection and
glucose metabolism derangements. Cross-sectional and longitudinal studies have shown …

The pathogenesis of liver damage associated with chronic hepatitis C virus (HCV) infection
is thought to be largely immunomediated. However, some frequent histopathological …

Soon after the hepatitis C virus (HCV) was identified in 1989, it was recognized that the
prevalence of infection in patients with ESRD far exceeded that in the general population …

New‐onset diabetes mellitus (NODM) develops in approximately 15% of liver transplant
recipients, and a similar proportion of patients have diabetes prior to transplantation …